What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly, we'll want to see a proven return on capital employed (ROCE) that is increasing, ...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key financial metrics. One common approach is to try and find a company with returns ...

JOHANNESBURG, May 31 (Reuters) - South African pharmacy chain Dis-Chem Pharmacies (DCPJ.J), opens new tab reported a 1.6% decline in full-year earnings on Friday reflecting a strong previous year and ...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) and secondly, an ...

Dis-Chem Pharmacies’ share price slumped 5.5% on Friday despite reporting good annual earnings growth and solid revenue growth for the first quarter to May 27. Group revenue grew by 8.6% for the three ...

Dis-Chem reported a 7.2% group revenue growth during the period from 1 September 2024 to 31 January 2025. On Friday the pharmacy group published its trading update for the five months ended in January ...

Dis-Chem Pharmacies increased group revenue by 7.2% in the five months to January 31, 2025, and the recovery in retail that was seen in January continued into February. "The retail revenue recovery ...

JOHANNESBURG (Reuters) - South Africa's Dis-Chem plans to double in size over the next five years its chief executive said on Friday, as the drug store chain made its debut on the Johannesburg bourse.

South African drug-store chain Dis-Chem Pharmacies said on Monday it would take stakes in two software firms and had signed a deal to buy healthcare group Medicare Health for 282 million rand ($19.13 ...

25 Oct 2024 (Johannesburg Stock Exchange) Dis-Chem Pharmacies Limited has reported a 9.6% increase in group revenue for the six-month period ended August 31, 2024, reaching R19.60 billion, according ...

The company said revenue however, rose by 11.1 per cent to 36.3 billion rand ($1.93 billion) with retail revenue up 9.7 per cent to 31.7 billion and comparable pharmacy store revenue up 6.9 per cent.